Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Epoxide Hydrolase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104531630B enables high-enantioselectivity enzyme mutants. Achieve substantial cost reduction in pharma intermediates manufacturing with scalable biocatalysis.
Patent CN102994470A details a novel Aus EH-B enzyme for high-purity chiral epichlorohydrin. Discover cost-effective biocatalytic solutions for pharmaceutical intermediates.
Patent CN105734028A reveals high-efficiency epoxide hydrolase mutants for R-epichlorohydrin production, offering superior stability and supply chain reliability.
Patent CN105734028A reveals mutant epoxide hydrolase for high-purity R-epichlorohydrin. Enhances stability and activity for reliable pharmaceutical intermediate supply chains.
Patent CN103013945B details a novel epoxide hydrolase mutant enhancing hydrolytic activity and enantioselectivity for beta-blocker synthesis, offering significant cost and supply chain advantages.